At present, however, there is considerable scope for improvement in drugs for these conditions, but approvals of drugs with novel mechanisms of action for CNS disorders have been rare in recent years.

Merger and acquisition (M&A) activity in the MENA region surged in 2024, recording 701 deals valued at $92.3bn, according to the latest EY MENA M&A Insights 2024 report. The figures mark a 3 per ...

This scheme will be implemented from July 2025. The Budget 2025 also announced that Withholding Tax (WHT) will not be deducted by a financial institution from the interest paid on deposit made with ...

1,800,000/- for any year of assessment, will be entitled to a refund of withholding tax (WHT) deducted on interest. This is under the existing refund scheme for senior citizens. The Commissioner ...

Newleos Ther­a­peu­tics emerged Thurs­day with $93.5 mil­lion and a bun­dle of oral small mol­e­cules that it li­censed from Roche, fur­ther demon­strat­ing that the phar­ma-to-start ...

Boston, USA-based Newleos Therapeutics, a neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, has announced its emergence and the closing of an ...